Logo En IconLogo Mark IconIcelandic Intellectual Property Office
Plus Black IconMortgagePlus Black IconLicense

SPC208

Obinutuzumab í samsettri meðferð með Bendamustine

  • Status:
    Veitt
  • Application date:
    30.10.2017
  • Application published:
    15.3.2023
  • Grant published:
    15.3.2023
  • Max expiry date:
    14.6.2031
  • Medicine name:
    Gazyvaro
  • Medicine for children:
    No

Timeline

Today
30.10.2017Application
15.3.2023Publication
15.3.2023Registration
14.6.2031Expires

Marketing license

  • IS authorization number:
    EU/1/14/937/001
  • Date:
    23.7.2014
  • Foreign authorization number:
    EU/1/14/937
  • Date:
    13.6.2016

Owner

  • Name:
    Roche Glycart AG
  • Address:
    Wagistrasse 18, Schlieren-Zuerich CH

Agent

  • Name:
    Örn Þór slf.
  • Address:
    Klukkuvöllum 17, 221 Hafnarfirði

Patent

Deadlines

TypeDeadline until

Type: Frestur til að fara yfir drög að vottorði

Deadline until: 04.02.2023

Upload documents